Basket | Login | Register

 
 
 
 

Clinical trials by country

Phase II trials

Austria

  1. LM11A-31-BHS

Czech Republic

  1. LM11A-31-BHS

Finland

  1. ACI-24-1801

France

  1. ABvac40
  2. ETHERAL
  3. LAURIET

Germany

  1. LM11A-31-BHS

Italy

  1. ABvac40

Poland

  1. ACI-24-1801 (planned)
  2. LAURIET

Spain

  1. ABvac40
  2. ETHERAL
  3. LAURIET
  4. LM11A-31-BHS

Sweden

  1. ABvac40
  2. ACI-24-1801
  3. LM11A-31-BHS
  4. VALZ-Pilot

UK

  1. ACI-24-1801
  2. DESPIAD
  3. ETHERAL

 

 
 

Last Updated: Monday 24 February 2020

 

 
  • Acknowledgements

    Alzheimer Europe's Clinical Trial Watch received funding under an operating grant from the European Union’s Health Programme (2014–2020).
  • European Union
 
 

Options